arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Pyxis Oncology, Inc.

PYXS

$3.22 ▼ -0.12 (-3.59%) at close

27 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Pyxis Oncology, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $206.1M

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC -227.2% ↘

FCF / Share $-0.28 ↗

Trailing P/E —

Price / Book 17.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$11.04M

— —

Net Income Profit after all expenses

$-23.27M

↓ -10.0% —

Operating Margin Operating profit as % of sales

-165.7%

↓ -377.5% —

FCF / Share Free cash flow per share

$-0.28

↑ +30.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-3.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-483.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-78.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	29.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	88.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	68.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	34.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	48.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	90.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	85.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-10.0% Weak ↓ Weak Declining Year-over-year change in net income	-10.0% Weak ↑ Weak Improving Year-over-year change in net income	49.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-3.8% Weak ↑ Weak Improving Year-over-year change in net income	-549.8% Weak ↓ Weak Declining Year-over-year change in net income	-549.8% Weak ↓ Weak Declining Year-over-year change in net income	-128.1% Weak ↓ Weak Declining Year-over-year change in net income	8.0% Fair ↓ Fair Declining Year-over-year change in net income	83.1% Excellent ↑ Excellent Improving Year-over-year change in net income	83.1% Excellent ↑ Excellent Improving Year-over-year change in net income	56.8% Excellent ↑ Excellent Improving Year-over-year change in net income	16.7% Good ↑ Good Improving Year-over-year change in net income	38.7% Excellent ↑ Excellent Improving Year-over-year change in net income	38.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-114.5% Weak ↓ Weak Declining Year-over-year change in net income	-95.2% Weak ↓ Weak Declining Year-over-year change in net income	14.8% Fair ↑ Fair Improving Year-over-year change in net income	14.8% Fair ↑ Fair Improving Year-over-year change in net income	-267.5% Weak Weak Year-over-year change in net income	-624.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-11.0% Weak Weak Year-over-year change in free cash flow	—	12.1% Fair Fair Year-over-year change in free cash flow	—	9.6% Fair Fair Year-over-year change in free cash flow	—	—	85.6% Excellent Excellent Year-over-year change in free cash flow	53.8% Excellent Excellent Year-over-year change in free cash flow	—	—	52.9% Excellent Excellent Year-over-year change in free cash flow	—	—	83.5% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	-165.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1205%)	—	—	—	—	—	—	-34.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-331%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-6.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-164.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1467%)	—	—	—	—	—	—	-20.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-268%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-94.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-129.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.78x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	6.43x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.62x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.07x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-227.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-2.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	56.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-47.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-25.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-11.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-18.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-45.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-203.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1456%)	-74.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-596%)	-33.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-326%)	-32.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-24.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-20.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-29.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-13.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-1.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-1.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-16.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-13.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-22.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-14.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-13.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-6.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	19.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+32%)	63.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+326%)	73.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+391%)	29.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+95%)	17.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+18%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-18.86M	$-5.77M	$-15.42M	$-8.92M	$-10.73M	$-12.76M	$-19.47M	$-12.06M	$-25.07M	$-27.97M	$-9.66M	$-14.71M	$-25.90M	$-53.06M	$-179.29M	$-198.54M	$-223.35M	$-247.09M	$-274.74M	$-133.48M	$-142.47M	$-140.66M	$-8.08M	$-11.25M	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	$0.00	$0.05	—	—	$0.00	$0.00	$0.31	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.40	$-0.37	$-0.29	$-0.35	$-0.30	$-0.35	$-0.59	$-0.35	$-0.29	$-0.06	$-0.33	$-0.56	$-0.41	$-0.54	$-1.04	$-0.85	$-0.79	—	$31.32	$-8.96	$-5.54	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.28	$-0.41	—	$-0.21	—	$-0.37	—	$-0.24	$-0.05	$-0.41	—	—	$-0.35	$-0.88	—	$-0.76	$-0.73	—	—	$-4.61	$1.69	—	—	—	—	—	—
Book Value per Share (USD)	$0.18	$0.50	$0.85	$1.11	$1.41	$1.67	$2.01	$2.53	$2.81	$3.13	$2.81	$3.11	$3.78	$4.12	$4.60	$5.80	$6.53	$7.21	$8.11	$-45.17	$-39.14	—	$-12.13	—	—	—	—
Tangible Book Value per Share (USD)	$0.18	$0.50	$0.85	$1.07	$1.37	$1.63	$1.97	$2.53	$2.81	$2.73	$2.27	$2.61	$3.78	$4.12	$4.60	$5.80	$6.53	$7.21	$8.11	$-45.17	$-39.14	—	$-12.13	—	—	—	—
Basic Weighted Avg Shares (shares)	63.99M	63.47M	—	62.56M	61.92M	61.05M	—	60.72M	60.50M	51.29M	—	41.33M	38.39M	35.35M	—	32.56M	32.45M	—	—	1.58M	1.47M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$9.26M	$29.04M	$50.97M	$63.69M	$82.28M	$97.44M	$114.76M	—	—	$158.24M	$98.84M	$110.76M	—	$144.58M	$154.98M	—	—	$232.07M	$259.96M	—	—	—	$4.41M	—	—	—	—
Total Equity (USD)	$11.44M	$31.27M	$53.41M	$68.78M	$87.64M	$103.10M	$120.75M	$153.68M	$169.79M	$184.16M	$125.70M	$137.95M	$145.28M	$152.16M	$160.82M	$188.75M	$211.97M	$233.51M	$261.31M	$-71.44M	$-57.59M	$-50.02M	$-15.64M	$-11.09M	$-7.91M	$-4.82M	$-2.87M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$11.04M	$0.00	$2.82M	—	$0.00	$0.00	$0.00	$16.15M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$301.00K	$459.00K	$2.90M	$527.00K	—	$552.00K	$550.00K	$731.00K	$585.00K	$1.12M	$690.00K	—	$524.00K	$190.00K	$192.00K	$200.00K	$159.00K	$158.00K	$158.00K	$159.00K	$217.00K	$113.00K	$170.00K	—	—	—	—
Net Income, GAAP (USD)	$-23.27M	$-23.27M	$-18.11M	$-22.00M	$-21.16M	$-21.16M	$-35.57M	$-21.20M	$-3.26M	$-3.26M	$-15.60M	$-23.05M	$-19.24M	$-19.24M	$-36.10M	$-27.67M	$-31.38M	$-31.38M	$-16.83M	$-14.18M	$-36.83M	$-36.83M	$-4.58M	$-1.96M	—	—	—
Operating Cash Flow (USD)	$-18.21M	$-26.00M	$-10.43M	$-13.28M	—	$-22.54M	$-19.29M	$-14.66M	$-3.01M	$-20.71M	$-15.25M	—	$-11.03M	$-26.84M	$-17.39M	$-20.56M	$-23.71M	$-27.68M	$-12.17M	$-7.29M	$2.86M	$-18.73M	$-3.17M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Pyxis Oncology, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PYXS with peers